Peripheral Neuropathy Trial, Recruiting NCT06904989 Sponsor: Vastra Gotaland Region Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06904989
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have breast cancer and are receiving treatment at the Oncology Department at Sahlgrenska University Hospital.
  • You have previously been treated with a type of chemotherapy called taxanes.
  • You are 18 years old or older.
  • You are able to understand spoken and written Swedish.
  • You are able to walk, either on your own or with the help of a walking aid (such as a cane or walker).
  • A doctor has rated your symptoms at a certain level of severity (above level 2 on a standard medical scale) during a visit after finishing treatment (confirm with trial site).

Who may not be able to join:

  • You have had both legs amputated at or above the thigh.
  • You have previously been diagnosed with a neurological condition (a disease affecting the nerves or brain) that affects feeling or movement in your feet.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ulla Hellstrand Tang, Orthopedic engineer, Vastragotaland regionen

Phone: 0046705568678

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Vastra Gotaland Region
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Change in foot neuropathy grade after 3-6 weeks of using the silicone orthosis.; Change in Change in physical activity level after 3-6 weeks of using the silicone orthosis.; Change in foot neuropathy symptoms after 3-6 weeks of using the silicone orthosis.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov